Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person An antihypotensive agent (vasopressor agent, pressor) is any...
| Class:Id | Summation:9623403 |
|---|---|
| _displayName | An antihypotensive agent (vasopressor agent, pressor) is any... |
| _timestamp | 2018-11-13 11:02:34 |
| created | [InstanceEdit:9623402] Jassal, Bijay, 2018-10-04 |
| literatureReference | [LiteratureReference:9626151] Microphysiometric analysis of human alpha1a-adrenoceptor expressed in Chinese hamster ovary cells [LiteratureReference:9626157] Agonist pharmacology at recombinant α1A - and α1L -adrenoceptors and in lower urinary tract α1 -adrenoceptors [LiteratureReference:9626200] Vascular effects of topical oxymetazoline on human nasal mucosa [LiteratureReference:9626201] Use of oxymetazoline in the management of epistaxis [LiteratureReference:9626191] The pharmacology of alpha-adrenergic decongestants [LiteratureReference:9626162] Non-prescription sympathomimetic agents and hypertension [LiteratureReference:9626193] Pharmacokinetics, safety, and cardiovascular tolerability of phenylephrine HCl 10, 20, and 30 mg after a single oral administration in healthy volunteers [LiteratureReference:9627260] The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries [LiteratureReference:9627256] {alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium [LiteratureReference:9627263] Vasopressor agents for cardiopulmonary resuscitation [LiteratureReference:9627253] Vasoconstrictor responses to vasopressor agents in human pulmonary and radial arteries: an in vitro study |
| modified | [InstanceEdit:9623419] Jassal, Bijay, 2018-10-04 [InstanceEdit:9626120] Jassal, Bijay, 2018-10-25 [InstanceEdit:9626209] Jassal, Bijay, 2018-10-25 [InstanceEdit:9627264] Jassal, Bijay, 2018-11-01 [InstanceEdit:9627267] Jassal, Bijay, 2018-11-01 [InstanceEdit:9628794] Jassal, Bijay, 2018-11-13 |
| text | An antihypotensive agent (vasopressor agent, pressor) is any medication that tends to raise a reduced blood pressure. Antihypotensive drugs can act as vasoconstrictors to increase total peripheral resistance, others sensitise adrenoreceptors to catecholamines and the third class can increase cardiac output. Sympathomimetic drugs (also known as adrenergic drugs and adrenergic amines) are stimulant compounds which mimic the effects of endogenous agonists (the catecholamines epinephrine and norepinephrine and dopamine) of the sympathetic nervous system. Sympathomimetic drugs are used to treat cardiac arrest and low blood pressure, among other uses (Cao et al. 2003, Jensen et al. 2011, Currigan et al. 2014). The α1-agonist drugs selectively stimulate α1-adrenoceptors, mimicking the action of epinephrine and norepinephrine signaling in the heart, smooth muscle and central nervous system (Horie et al. 1995, review Perez 2007). There are three homologous subtypes of α1-adrenoceptors: α1A, α1B, and α1D. The α1A- and α1B-adrenoceptors are expressed in the rodent and human heart (Jensen et al. 2009a), whereas the α1D-adrenoceptor is found in the coronary vasculature and mediates vasoconstriction (Jensen et al. 2009b). α1-adrenoceptors are GPCRs coupled to the heterotrimeric G protein Gq, which, upon receptor activation, activates phospholipase C (PLC). PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2), which in turn causes an increase in inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 interacts with calcium channels on the endoplasmic and sarcoplasmic reticulum, releasing Ca2+ from stores and increasing intracellular Ca2+ levels and subsequently, causes smooth muscle contraction in blood vessels, GI tract, kidney, brain, skin, bladder and the eye. Drugs that act as α1-adrenoceptor agonists are used as vasopressors, for urinary incontinence and in nasal decongestants. Methoxamine is an brain-penetrant α1-adrenoceptor agonist (Taniguchi et al. 1999) and may be useful for stress urinary incontinence (SUI) therapy (Yoshiki et al. 2013). Oxymetazoline (SCH-9384, Vicks Sinex) is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose) caused by allergies or the common cold (Bende & Löth 1986). Due to its vasoconstricting properties, oxymetazoline is also used to treat nose bleeds (Krempl & Noorily 1995). Phenylephrine is a selective α1-adrenergic receptor agonist (Taniguchi et al. 1999) of the phenethylamine class used primarily as a decongestant (Johnson & Hricik 1993), as an agent to dilate the pupil, to increase blood pressure (vasopressor), and to relieve hemorrhoids. It is well tolerated at therapeutic doses, with only higher doses producing any significant rises in blood pressure (Chua & Benrimoj 1988, Gelotte & Zimmerman 2015). |
| (summation) | [Reaction:9623384] α1-agonists bind ADRA1A,B,D [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by An antihypotensive agent (vasopressor agent, pressor) is any... (9623403)
